The US Food and Drug Administration (FDA) is warning physicians that data from both clinical and industry sources suggests that the occurrence of Type III endoleaks in patients who have undergone ...

The lack of any presence of endoleak at the initial imaging after endovascular aortic aneurysm repair (EVAR) is predictive of good midterm outcomes with less need for reintervention. As such, patients ...

SILVER SPRING, MD — There appears to have been an increase in type IIIa and IIIb endoleaks with endovascular graft systems used for endovascular aneurysm repair (EVAR), the US Food and Drug ...

Endovascular aneurysm repair is a minimally invasive technique for the treatment of abdominal aortic aneurysms—life-threatening bulges in the aorta's abdominal section. However, it carries the risk of ...

Thoracic endovascular aortic repair (TEVAR) effectively improved the results of thoracic aortic aneurysm treatment. TEVAR is a less invasive procedure that can be performed under local anesthesia with ...

Dr. Matt Thompson, Chief Medical Officer of Endologix Inc. commented, “On September 28, 2017, the FDA issued a letter to health care professionals (“HCPs”) regarding Type III endoleaks after ...

The one-year data covers 94 high surgical risk patients across all arms.

Abdominal aortic aneurysm (AAA) repair has evolved into a multifaceted field incorporating both traditional open surgical techniques and less invasive endovascular procedures (EVAR). The management of ...

Please provide your email address to receive an email when new articles are posted on . The FDA’s Circulatory System Devices Panel advised that for a stent graft system to treat patients with ...

The wireless and implantable sensor is robust enough to withstand dynamic process of being crimped into a catheter and deployed inside the vessel SEOUL, South Korea, Oct. 22, 2025 /PRNewswire/ -- ...